Yasushi Yoshimura

Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma Cells

Toshihiko Ohtomo, Yasuhiro Sugamata, Yasuko Ozaki et al. · Biochemical and Biophysical Research Communications · 1999 · 199 citations

Histocompatibility, Immunology, Antigen Processing +6

The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic <i>PIK3CA</i> Mutations

Hiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura et al. · Clinical Cancer Research · 2011 · 95 citations

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Takahiro Tsuji, Hiroaki Ozasa, Wataru Aoki et al. · Nature Communications · 2020 · 80 citations · Full text

Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent

Yoshiaki Isshiki, Yasunori Kohchi, Hitoshi Iikura et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 76 citations · Full text

Medicinal Chemistry, Medicine, Available Anticancer Agent +6

Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma

Yasufumi Kikuchi, Shinsuke Uno, Yasuko Kinoshita et al. · Leukemia Research · 2004 · 68 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +9